¼¼°èÀÇ ¸ê±Õ Æ©ºê ¿ëÁ¢±â ½ÃÀå
Sterile Tubing Welder
»óǰÄÚµå : 1595020
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 11¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 93 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,056,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,169,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ¸ê±Õ Æ©ºê ¿ëÁ¢±â ½ÃÀåÀº 2030³â±îÁö 33¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2023³â¿¡ 25¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ ¸ê±Õ Æ©ºê ¿ëÁ¢±â ½ÃÀåÀº ºÐ¼® ±â°£ÀÎ 2023-2030³â¿¡ CAGR 4.1%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 33¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ ÀÚµ¿ ¿ëÁ¢±â´Â CAGR 4.5%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á±îÁö 28¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¼öµ¿ ¿ëÁ¢±â ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£¿¡ CAGR 2.3%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 6¾ï 6,860¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 7.0%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ¸ê±Õ Æ©ºê ¿ëÁ¢±â ½ÃÀåÀº 2023³â¿¡ 6¾ï 6,860¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2023-2030³â CAGRÀ» 7.0%·Î¼­ 2030³â¿¡´Â 6¾ï 8,720¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 2.1%¿Í 3.4%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 2.7%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ¸ê±Õ Æ©ºê ¿ëÁ¢±â ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¸ê±Õ Æ©ºê ¿ëÁ¢±â´Â ¹ÙÀÌ¿ÀÀǾàǰ Á¦Á¶¸¦ ¾î¶»°Ô Áö¿øÇϰí Àִ°¡?

¸ê±Õ Æ©ºê ¿ëÁ¢±â´Â ¹ÙÀÌ¿ÀÀǾàǰ Á¦Á¶¿¡¼­ ¿­°¡¼Ò¼º Æ©ºê Á¢ÇÕ¿¡ »ç¿ëµÇ´Â Áß¿äÇÑ Àåºñ·Î, ¹èÁö Áغñ, ¼¼Æ÷¹è¾ç, ¹ßÈ¿, ¿©°ú ¹× ±âŸ °øÁ¤¿¡¼­ ¹«±Õ ¿¬°áÀ» º¸ÀåÇÕ´Ï´Ù. ÀÌ Àåºñ´Â ¾×üÀÇ ¹«±Õ À̼ÛÀ» °¡´ÉÇÏ°Ô Çϰí, »ý»ê Àü¹Ý¿¡ °ÉÃÄ ¹«±Õ »óŸ¦ À¯ÁöÇÏ¿© ¿À¿° À§ÇèÀ» ÁÙÀÔ´Ï´Ù. ¸ê±Õ Æ©ºê À£´õ´Â ÀÏȸ¿ë ½Ã½ºÅÛ(SUS)¿¡ ³Î¸® »ç¿ëµÇ¸ç, ÀÏȸ¿ë ºÎǰÀ¸·Î ±³Â÷ ¿À¿°À» ÃÖ¼ÒÈ­ÇÏ°í ¿öÅ©Ç÷ο츦 °£¼ÒÈ­ÇÕ´Ï´Ù. ¹ÙÀÌ¿À Á¦¾à »ê¾÷ÀÌ ¹é½Å Á¦Á¶, »ý¹°ÇÐÀû Á¦Á¦ ¹× ±âŸ Ä¡·á¿¡ ÀÏȸ¿ë ±â¼ú(SUT)À» äÅÃÇÏ´Â °æÇâÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¸ê±Õ Æ©ºê ¿ëÁ¢±âÀÇ »ç¿ëÀº Ŭ¸°·ë ȯ°æ¿¡¼­ Á¦Ç° ¹«°á¼º ¹× ÀÛ¾÷ È¿À²¼ºÀ» À¯ÁöÇÏ´Â µ¥ ÇʼöÀûÀÔ´Ï´Ù.

¹«±Õ Æ©ºê ¿ëÁ¢±â ½ÃÀåÀÇ ÁÖ¿ä ºÎ¹®Àº ¹«¾ùÀΰ¡?

ÁÖ¿ä À¯Çü¿¡´Â ¼öµ¿ Æ©ºê ¿ëÁ¢±â¿Í ÀÚµ¿ Æ©ºê ¿ëÁ¢±â°¡ ÀÖÀ¸¸ç, ÀÚµ¿ Æ©ºê ¿ëÁ¢±â´Â È¿À²¼º, Á¤È®¼º ¹× ¿©·¯ ¿¬°áÀ» µ¿½Ã¿¡ ó¸®ÇÒ ¼ö ÀÖ´Â ´É·ÂÀ¸·Î ÀÎÇØ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ¿ëµµ¿¡´Â ¼¼Æ÷¹è¾ç ó¸®, ¹èÁö ¹× ¿ÏÃæ¾× Áغñ, ¹ßÈ¿, ÇÏ·ù Á¤Á¦ ¹× ÃÖÁ¾ ÃæÀüÀÌ Æ÷ÇԵǸç, ¼¼Æ÷¹è¾ç 󸮴 ´ÜŬ·Ð Ç×ü ¹× ¼¼Æ÷ Ä¡·áÁ¦ÀÇ »ý»ê Áõ°¡¿¡ µû¶ó Áß¿äÇÑ ºÎ¹®ÀÔ´Ï´Ù. ÃÖÁ¾»ç¿ëÀÚ¿¡´Â ¹ÙÀÌ¿À Á¦¾à ȸ»ç, ¿¬±¸ ±â°ü, À§Å¹ »ý»ê ±â°ü(CMO)ÀÌ Æ÷ÇԵǸç, ¹ÙÀÌ¿À Á¦¾à ȸ»ç´Â »ý¹°ÇÐÀû Á¦Á¦ ¹× ¹é½ÅÀÇ °íǰÁú »ý»êÀ» º¸ÀåÇϱâ À§ÇØ ¸ê±Õ Æ©ºê ¿ëÁ¢±â¸¦ µµÀÔÇÏ¿© ½ÃÀåÀ» ÁÖµµÇÏ´Â ÁÖ¿ä ±â¾÷ÀÔ´Ï´Ù.

¸ê±Õ Æ©ºê ¿ëÁ¢±â´Â ¹ÙÀÌ¿ÀÀǾàǰ Á¦Á¶¿¡ ¾î¶»°Ô Àû¿ëµÉ ¼ö Àִ°¡?

¼¼Æ÷¹è¾ç °øÁ¤¿¡¼­ ¸ê±Õ Æ©ºê À£´õ´Â ¼¼Æ÷¹è¾ç ¹èÁöÀÇ ¹«±Õ À̼ÛÀ» ÃËÁøÇÏ¿© ¿À¿° À§Çè ¾øÀÌ ¹ÙÀÌ¿À¸®¾×ÅÍ¿¡¼­ ¼¼Æ÷°¡ Áß´Ü ¾øÀÌ Áõ½ÄÇϰí È®ÀåÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ¹èÁö ¹× ¿ÏÃæ¾× Á¦Á¶¿¡¼­´Â ¾÷½ºÆ®¸² ¹× ´Ù¿î½ºÆ®¸² °øÁ¤À¸·Î Áß¿äÇÑ ¼ººÐÀ» À̼ÛÇÏ´Â µ¥ »ç¿ëµÇ´Â Æ©ºêÀÇ ¸ê±Õ ¿¬°áÀ» Áö¿øÇÏ¿© ÀϰüµÈ Á¦Ç° ǰÁúÀ» º¸ÀåÇÕ´Ï´Ù. ´Ù¿î½ºÆ®¸² Á¤Á¦ °øÁ¤¿¡¼­ ¸ê±Õ Æ©ºê À£´õ´Â ¿©°ú, Å©·Î¸¶Åä±×·¡ÇÇ, ³óÃàÀ» À§ÇÑ ¾ÈÁ¤ÀûÀÎ À¯Ã¼ À̼ÛÀ» °¡´ÉÇÏ°Ô ÇÏ¿© °í¼øµµ Á¤Á¦ °øÁ¤¿¡¼­ ¹«±Õ¼ºÀ» À¯ÁöÇÕ´Ï´Ù. ¶ÇÇÑ ¸ê±Õ Æ©ºê À£´õ´Â ÀǾàǰÀÇ ÃÖÁ¾ ÃæÀü¿¡µµ »ç¿ëµÇ¸ç, ¹Ì»ý¹° ¿À¿°À» ¹æÁöÇϰí ȯÀÚÀÇ ¾ÈÀüÀ» º¸ÀåÇϱâ À§ÇØ ¹«±Õ ¿¬°áÀÌ ÇÊ¿äÇÕ´Ï´Ù.

¹«±Õ Æ©ºê ¿ëÁ¢±â ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

¹«±Õ Æ©ºê ¿ëÁ¢±â ½ÃÀåÀÇ ¼ºÀåÀº Á¦Ç°ÀÇ ¾ÈÀü¼º°ú À¯È¿¼ºÀ» º¸ÀåÇϱâ À§ÇØ ¹«±Õ »óŸ¦ À¯ÁöÇÏ´Â °ÍÀÌ Áß¿äÇÑ ¹ÙÀÌ¿ÀÀǾàǰ Á¦Á¶¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µî ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. Æ©ºê Àç·áÀÇ °³¼±, ¿ëÁ¢ ½Ã°£ ´ÜÃà, ÀÚµ¿È­ ½Ã½ºÅÛ µî ÀÏȸ¿ë ±â¼ú(SUT)ÀÇ ¹ßÀüÀº ¸ê±Õ Æ©ºê ¿ëÁ¢±âÀÇ È¿À²¼º°ú ½Å·Ú¼ºÀ» Çâ»ó½ÃÄÑ ¹ÙÀÌ¿ÀÀǾàǰ Á¦Á¶¿¡ ³Î¸® Àû¿ëµÇ°í ÀÖ½À´Ï´Ù. ¹é½Å Á¦Á¶, »ý¹°ÇÐÀû Á¦Á¦, ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ °ü½ÉÀº º¹ÀâÇÑ Á¦Á¶ ¿öÅ©Ç÷ο쿡¼­ ¹«±Õ À¯Ã¼ À̼ÛÀ» À§ÇÑ ½Å·ÚÇÒ ¼ö ÀÖ´Â ¼Ö·ç¼ÇÀ» Á¦°øÇÏ´Â ¸ê±Õ Æ©ºê ¿ëÁ¢±â¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¹ÙÀÌ¿ÀÀǾàǰ ½Ã¼³¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡, ¹«±Õ 󸮿¡ ´ëÇÑ ±ÔÁ¦ ¿ä°Ç °­È­, CMOÀÇ ¼ºÀåÀÌ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ¹ÙÀÌ¿ÀÀǾàǰ Á¦Á¶ ȯ°æ¿¡¼­ ¸ê±Õ Æ©ºê ¿ëÁ¢±âÀÇ ÅëÇÕÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

¸ðµå(ÀÚµ¿, ¼öµ¿);ÃÖÁ¾ »ç¿ë(º´¿ø, Ç÷¾× ¼¾ÅÍ, Á¶»ç Ŭ¸®´Ð, ±âŸ ÃÖÁ¾ »ç¿ë)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹(ÁÖ¸ñ 42»ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Sterile Tubing Welder Market to Reach US$3.3 Billion by 2030

The global market for Sterile Tubing Welder estimated at US$2.5 Billion in the year 2023, is expected to reach US$3.3 Billion by 2030, growing at a CAGR of 4.1% over the analysis period 2023-2030. Automatic Welder, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$2.8 Billion by the end of the analysis period. Growth in the Manual Welder segment is estimated at 2.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$668.6 Million While China is Forecast to Grow at 7.0% CAGR

The Sterile Tubing Welder market in the U.S. is estimated at US$668.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$687.2 Million by the year 2030 trailing a CAGR of 7.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.1% and 3.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.

Global Sterile Tubing Welder Market - Key Trends and Drivers Summarized

How Are Sterile Tubing Welders Supporting Biopharmaceutical Manufacturing?

Sterile tubing welders are critical devices used to join thermoplastic tubing in biopharmaceutical production, ensuring sterile connections during processes like media preparation, cell culture, fermentation, and filtration. These devices enable aseptic transfer of fluids, maintaining sterility throughout production and reducing contamination risks. Sterile tubing welders are widely used in single-use systems (SUS), where disposable components minimize cross-contamination and streamline workflows. As the biopharmaceutical industry increasingly adopts single-use technologies (SUT) for vaccine production, biologics, and other therapies, the use of sterile tubing welders has become essential for maintaining product integrity and operational efficiency in cleanroom environments.

What Are the Key Segments in the Sterile Tubing Welder Market?

Key types include manual tubing welders and automated tubing welders, with automated tubing welders holding the largest market share due to their efficiency, precision, and ability to handle multiple connections simultaneously. Applications cover cell culture processing, media and buffer preparation, fermentation, downstream purification, and final filling, with cell culture processing representing a significant segment driven by the increasing production of monoclonal antibodies and cell therapies. End-users include biopharmaceutical companies, research institutes, and contract manufacturing organizations (CMOs), with biopharmaceutical companies leading the market as they implement sterile tubing welders to ensure high-quality production of biologics and vaccines.

How Are Sterile Tubing Welders Integrated Across Biopharmaceutical Production?

In cell culture processing, sterile tubing welders facilitate the aseptic transfer of cell culture media, enabling uninterrupted growth and expansion of cells in bioreactors without contamination risks. During media and buffer preparation, these devices support the sterile connection of tubing used to transfer critical components to upstream and downstream processes, ensuring consistent product quality. In downstream purification, sterile tubing welders enable secure fluid transfer for filtration, chromatography, and concentration, maintaining sterility during high-purity purification steps. Additionally, sterile tubing welders are used in the final filling of drug products, where aseptic connections are necessary to prevent microbial contamination and ensure patient safety.

What Factors Are Driving the Growth in the Sterile Tubing Welder Market?

The growth in the Sterile Tubing Welder market is driven by several factors, including increasing demand for biopharmaceutical production, where maintaining aseptic conditions is crucial for ensuring product safety and efficacy. Advancements in single-use technologies (SUT), such as improved tubing materials, faster welding times, and automated systems, have enhanced the efficiency and reliability of sterile tubing welders, supporting broader adoption across biopharmaceutical manufacturing. The focus on vaccine production, biologics, and personalized medicine has further fueled demand, as sterile tubing welders provide a reliable solution for aseptic fluid transfer in complex production workflows. Additionally, rising investments in biopharmaceutical facilities, increased regulatory requirements for aseptic processing, and the growth of CMOs have contributed to market growth, encouraging the integration of sterile tubing welders in biopharmaceutical manufacturing environments.

SCOPE OF STUDY:

The report analyzes the Sterile Tubing Welder market in terms of US$ Million by the following End-Use; Mode, and Geographic Regions/Countries:

Segments:

Mode (Automatic, Manual); End-Use (Hospitals, Blood Centers, Research Clinics, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â